Oscar Health is trading 4.3% down at $31.90, with healthcare-sector weakness the clearest reported context for the decline.
- No clear Oscar-specific announcement or analyst action dated October 23 explains the move; available information does not establish a company-specific catalyst.
- Broader markets were mixed at midday, rather than showing a uniform selloff.
- Current-session trading volume information was unavailable.